| 1 |
29958743 | Factor Xa inhibition and sPESI failure in intermediate-high-risk pulmonary embolism. | 2018 Oct |
1 |
| 2 |
28228055 | Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients. | 2017 Apr |
1 |
| 3 |
28781584 | Paget-Schroetter syndrome in the absence of common predisposing factors: a case report. | 2017 |
1 |
| 4 |
26031274 | Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved. | 2015 Jun |
1 |
| 5 |
23519234 | Relative effects of two different enoxaparin regimens as comparators against newer oral anticoagulants: meta-analysis and adjusted indirect comparison. | 2013 Aug |
3 |
| 6 |
22345487 | Enoxaparin dosing after discharge from US hospitals in patients with total knee replacement. | 2012 Sep |
1 |
| 7 |
22824193 | Therapeutic anticoagulation can be safely accomplished in selected patients with traumatic intracranial hemorrhage. | 2012 Jul 23 |
1 |
| 8 |
20825842 | Error in body weight estimation leads to inadequate parenteral anticoagulation. | 2011 Jul |
1 |
| 9 |
15249498 | Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin. | 2004 Jul 27 |
1 |
| 10 |
11062276 | Safety and cost of low-molecular-weight heparin as bridging anticoagulant therapy in subacute cerebral ischemia. | 2000 Nov |
1 |